Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade.
Hayashi H, Chamoto K, Hatae R, Kurosaki T, Togashi Y, Fukuoka K, Goto M, Chiba Y, Tomida S, Ota T, Haratani K, Takahama T, Tanizaki J, Yoshida T, Iwasa T, Tanaka K, Takeda M, Hirano T, Yoshida H, Ozasa H, Sakamori Y, Sakai K, Higuchi K, Uga H, Suminaka C, Hirai T, Nishio K, Nakagawa K, Honjo T. Hayashi H, et al. Among authors: tomida s. J Clin Invest. 2024 Apr 1;134(7):e168318. doi: 10.1172/JCI168318. J Clin Invest. 2024. PMID: 38557498 Free PMC article.
Topical application of activator protein-1 inhibitor T-5224 suppresses inflammation and improves skin barrier function in a murine atopic dermatitis-like dermatitis.
Sasakura M, Urakami H, Tachibana K, Ikeda K, Hasui KI, Matsuda Y, Sunagawa K, Ennishi D, Tomida S, Morizane S. Sasakura M, et al. Among authors: tomida s. Allergol Int. 2024 Apr;73(2):323-331. doi: 10.1016/j.alit.2023.12.006. Epub 2024 Feb 12. Allergol Int. 2024. PMID: 38350816 Free article.
Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study.
Urata T, Naoi Y, Jiang A, Boyle M, Sunami K, Imai T, Nawa Y, Hiramatsu Y, Yamamoto K, Fujii S, Yoshida I, Yano T, Chijimatsu R, Murakami H, Ikeuchi K, Kobayashi H, Tani K, Ujiie H, Inoue H, Tomida S, Yamamoto A, Kondo T, Fujiwara H, Asada N, Nishimori H, Fujii K, Fujii N, Matsuoka KI, Sawada K, Momose S, Tamaru JI, Nishikori A, Sato Y, Yoshino T, Maeda Y, Scott DW, Ennishi D. Urata T, et al. Among authors: tomida s. Blood Adv. 2023 Dec 26;7(24):7459-7470. doi: 10.1182/bloodadvances.2023010402. Blood Adv. 2023. PMID: 37552496 Free PMC article.
[Ⅲ. The Role of Comprehensive Genomic Profiling in Sarcoma].
Nakata E, Fujiwara T, Kunisada T, Ozaki T, Toyooka S, Ennishi D, Yamamoto H, Ninomiya K, Tomida S, Hirasawa A, Futagawa M, Tabata M. Nakata E, et al. Among authors: tomida s. Gan To Kagaku Ryoho. 2023 Mar;50(3):314-320. Gan To Kagaku Ryoho. 2023. PMID: 36927899 Japanese. No abstract available.
Transcriptome analysis of the cytokine storm-related genes among the subtypes of idiopathic multicentric Castleman disease.
Nishikori A, Nishimura MF, Tomida S, Chijimatsu R, Ueta H, Lai YC, Kawahara Y, Takeda Y, Ochi S, Haratake T, Ennishi D, Nakamura N, Momose S, Sato Y. Nishikori A, et al. Among authors: tomida s. J Clin Exp Hematop. 2024 Dec 25;64(4):297-306. doi: 10.3960/jslrt.24061. Epub 2024 Oct 28. J Clin Exp Hematop. 2024. PMID: 39462545 Free article.
Handling of Germline Findings in Clinical Comprehensive Cancer Genomic Profiling.
Okazawa-Sakai M, Yamamoto Y, Futagawa M, Okamura M, Miyawaki S, Nishina T, Takehara K, Kozuki T, Tomida S, Hyodo I, Ohsumi S, Hirasawa A. Okazawa-Sakai M, et al. Among authors: tomida s. Acta Med Okayama. 2022 Dec;76(6):673-678. doi: 10.18926/AMO/64117. Acta Med Okayama. 2022. PMID: 36549769 Free article.
238 results